NVTA - Invitae Non-GAAP EPS of -$0.34 beats by $0.19 revenue of $122.45M beats by $1.47M
- Invitae press release ( NYSE: NVTA ): Q4 Non-GAAP EPS of -$0.34 beats by $0.19 .
- Revenue of $122.45M (-2.9% Y/Y) beats by $1.47M .
- Entered into a ~$336 million transaction for the 2024 convertible notes, effectively addressing ~96% of the amount outstanding.
- Repaid its 2024 senior secured term loan in full, improving its balance sheet.
- Company maintains cash runway through the end of 2024
- Annual revenue grew by 12.1%; Continued to improve on key financial metrics.
- Major initiatives under strategic realignment largely completed.
- Guiding to low double digit pro forma revenue growth and continued expansion of non-GAAP gross margin in 2023, decreasing cash burn by over 45% from 2022.
- Total active healthcare provider accounts totaled 20,929 as of December 31, 2022, an increase of approximately 13% year-over-year.
- Total patient population as of December 31, 2022 is more than 3.6 million with over 62% available for data sharing.
- Shares +1.86% .
For further details see:
Invitae Non-GAAP EPS of -$0.34 beats by $0.19, revenue of $122.45M beats by $1.47M